Abstract
Eph receptor tyrosine kinases and their ligands, the ephrins, perform an important regulatory function in tissue organization, as well as participate in malignant transformation of cells. Ephrin-A1, a ligand of A class Eph receptors, is a modulator of tumor growth and progression, and the mechanism of its action needs detailed investigation. Here we report on the development of a system for bacterial expression of an ephrin-A1 receptor-binding domain (eA1), a procedure for its purification, and its renaturation with final yield of 50 mg/liter of culture. Functional activity of eA1 was confirmed by immunoblotting, laser scanning confocal microscopy, and flow cytometry. It is shown that monomeric non-glycosylated receptor-binding domain of ephrin-A1 is able to activate cellular EphA2 receptors, stimulating their phosphorylation. Ligand eA1 can be used to study the features of ephrin-A1 interactions with different A class Eph receptors. The created expression cassette is suitable for the development of ligands with increased activity and selectivity and experimental systems for the delivery of cytotoxins into tumor cells that overexpress EphA2 or other class A Eph receptors.
Similar content being viewed by others
Abbreviations
- aa:
-
amino acid residue
- β-ME:
-
β-mercaptoethanol
- CFP:
-
cyan fluorescent protein
- eA1:
-
receptor-binding domain of ephrin-A1
References
Holder, N., and Klein, R. (1999) Development, 126, 2033–2044.
Kullander, K., and Klein, R. (2002) Nat. Rev. Mol. Cell. Biol., 3, 475–486.
Pasquale, E. B. (2010) Nat. Rev. Cancer, 10, 165–180.
Wykosky, J., and Debinski, W. (2008) Mol. Cancer Res., 6, 1795–1806.
Shao, H., Pandey, A., O’shea, K. S., Seldin, M., and Dixit, V. M. (1995) J. Biol. Chem., 270, 5636–5641.
Himanen, J. P., Goldgur, Y., Miao, H., Myshkin, E., Guo, H., Buck, M., Nguyen, M., Rajashankar, K. R., Wang, B., and Nikolov, D. B. (2009) EMBO Rep., 10, 722–728.
Pasquale, E. B. (1997) Curr. Opin. Cell. Biol., 9, 608–615.
Choi, S., Jeong, J., Kim, T., and Park, S. (1999) Mol. Cells, 9, 440–445.
Janes, P. W., Saha, N., Barton, W. A., Kolev, M. V., Wimmer-Kleikamp, S. H., Nievergall, E., Blobel, C. P., Himanen, J. P., Lackmann, M., and Nikolov, D. B. (2005) Cell, 123, 291–304.
Walker-Daniels, J., Riese, D. J., and Kinch, M. S. (2002) Mol. Cancer Res., 1, 79–87.
Bartley, T. D., Hunt, R. W., Welcher, A. A., Boyle, W. J., Parker, V. P., Lindberg, R. A., Lu, H. S., Colombero, A. M., Elliott, R. L., Guthrie, B. A., Holst, P. L., Skrine, J. D., Toso, R. J., Zhang, M., Fernandez, E., Trail, G., Varnum, B., Yarden, Y., Hunter, T., and Fox, G. M. (1994) Nature, 368, 558–560.
Easty, D. J., Guthrie, B. A., Maung, K., Farr, C. J., Lindberg, R. A., Toso, R. J., Herlyn, M., and Bennett, D. C. (1995) Cancer Res., 55, 2528–2532.
Davis, S., Gale, N. W., Aldrich, T. H., Maisonpierre, P. C., Lhotak, V., Pawson, T., Goldfarb, M., and Yancopoulos, G. D. (1994) Science, 266, 816–819.
Himanen, J. P., and Nikolov, D. B. (2003) Trends Neurosci., 26, 46–51.
Duxbury, M. S., Ito, H., Zinner, M. J., Ashley, S. W., and Whang, E. E. (2004) Biochem. Biophys. Res. Commun., 320, 1096–1102.
Noblitt, L. W., Bangari, D. S., Shukla, S., Knapp, D. W., Mohammed, S., Kinch, M. S., and Mittal, S. K. (2004) Cancer Gene Ther., 11, 757–766.
Noblitt, L. W., Bangari, D. S., Shukla, S., Mohammed, S., and Mittal, S. K. (2005) Cancer Gene Ther., 12, 46–53.
Tandon, M., Vemula, S. V., Sharma, A., Ahi, Y. S., Mittal, S., Bangari, D. S., and Mittal, S. K. (2012) J. Gene Med., 14, 77–89.
Gobin, A. M., Moon, J. J., and West, J. L. (2008) Int. J. Nanomedicine, 3, 351–358.
Wykosky, J., Gibo, D. M., and Debinski, W. (2007) Mol. Cancer Therap., 6, 3208–3218.
Wykosky, J., Palma, E., Gibo, D. M., Ringler, S., Turner, C. P., and Debinski, W. (2008) Oncogene, 27, 7260–7273.
Alford, S., Watson-Hurthig, A., Scott, N., Carette, A., Lorimer, H., Bazowski, J., and Howard, P. L. (2010) Cancer Cell Int., 10, 41.
Lema Tome, C. M., Palma, E., Ferluga, S., Lowther, W. T., Hantgan, R., Wykosky, J., and Debinski, W. (2012) J. Biol. Chem., doi: 10.1074/jbc.M111.311670.
Chomczynski, P., and Sacchi, N. (1987) Anal. Biochem., 162, 156–159.
Laemmli, U. K. (1970) Nature, 227, 680–685.
Provencher, S. W., and Glockner, J. (1981) Biochemistry, 20, 33–37.
Sharonov, G. V., Astapova, M. V., Kolosov, P. M., Arseniev, A. S., and Feofanov, A. V. (2009) in Proc. Int. Conf. “Reception and Intracellular Signaling” (Zinchenko, V. P., Kolesnikova, S. S., and Berezhnova, A. V., eds.) Pushchino, ISBN 978-5-904385-09-5, Vol. 2, pp. 751–757.
Wulfson, A. N., Tikhonov, R. V., and Pechenov, S. E. (2001) Doklady Biochem. Biophys., 380, 329–332.
Himanen, J. P., Yermekbayeva, L., Janes, P. W., Walker, J. R., Xu, K., Atapattu, L., Rajashankar, K. R., Mensinga, A., Lackmann, M., Nikolov, D. B., and Dhe-Paganon, S. (2010) Proc. Natl. Acad. Sci. USA, 107, 10860–10865.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Russian in Biokhimiya, 2012, Vol. 77, No. 12, pp. 1705–1714.
Rights and permissions
About this article
Cite this article
Nekrasova, O.V., Sharonov, G.V., Tikhonov, R.V. et al. Receptor-binding domain of ephrin-A1: Production in bacterial expression system and activity. Biochemistry Moscow 77, 1387–1394 (2012). https://doi.org/10.1134/S0006297912120073
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297912120073